These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 31600821)

  • 1. Application of the 2017 criteria for vascular Ehlers-Danlos syndrome in 50 patients ascertained according to the Villefranche nosology.
    Ritelli M; Rovati C; Venturini M; Chiarelli N; Cinquina V; Castori M; Colombi M
    Clin Genet; 2020 Feb; 97(2):287-295. PubMed ID: 31600821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multi-institutional experience in the aortic and arterial pathology in individuals with genetically confirmed vascular Ehlers-Danlos syndrome.
    Shalhub S; Byers PH; Hicks KL; Charlton-Ouw K; Zarkowsky D; Coleman DM; Davis FM; Regalado ES; De Caridi G; Weaver KN; Miller EM; Schermerhorn ML; Shean K; Oderich G; Ribeiro M; Nishikawa C; Behrendt CA; Debus ES; von Kodolitsch Y; Powell RJ; Pepin M; Milewicz DM; Lawrence PF; Woo K
    J Vasc Surg; 2019 Nov; 70(5):1543-1554. PubMed ID: 31126764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multi-institutional experience in vascular Ehlers-Danlos syndrome diagnosis.
    Shalhub S; Byers PH; Hicks KL; Coleman DM; Davis FM; De Caridi G; Weaver KN; Miller EM; Schermerhorn ML; Shean K; Oderich G; Ribeiro M; Nishikawa C; Charlton-Ouw K; Behrendt CA; Debus ES; von Kodolitsch Y; Zarkowsky D; Powell RJ; Pepin M; Milewicz DM; Regalado ES; Lawrence PF; Woo K
    J Vasc Surg; 2020 Jan; 71(1):149-157. PubMed ID: 31353273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of Clinical Diagnostic Criteria for Patients With Vascular Ehlers-Danlos Syndrome in a Tertiary Referral Centre.
    Henneton P; Albuisson J; Adham S; Legrand A; Mazzella JM; Jeunemaitre X; Frank M
    Circ Genom Precis Med; 2019 Mar; 12(3):e001996. PubMed ID: 30919682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amniotic band sequence in paternal half-siblings with vascular Ehlers-Danlos syndrome.
    Callaghan MB; Hadden R; King JS; Lachlan K; van Dijk FS; Turnpenny PD
    Am J Med Genet A; 2020 Mar; 182(3):553-556. PubMed ID: 31833208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous pneumothorax and hemothorax frequently precede the arterial and intestinal complications of vascular Ehlers-Danlos syndrome.
    Shalhub S; Neptune E; Sanchez DE; Dua A; Arellano N; McDonnell NB; Milewicz DM
    Am J Med Genet A; 2019 May; 179(5):797-802. PubMed ID: 30793832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical COL3A1 variants (glutamic acid to lysine) cause vascular Ehlers-Danlos syndrome with a consistent phenotype of tissue fragility and skin hyperextensibility.
    Ghali N; Baker D; Brady AF; Burrows N; Cervi E; Cilliers D; Frank M; Germain DP; Hulmes DJS; Jacquemont ML; Kannu P; Lefroy H; Legrand A; Pope FM; Robertson L; Vandersteen A; von Klemperer K; Warburton R; Whiteford M; van Dijk FS
    Genet Med; 2019 Sep; 21(9):2081-2091. PubMed ID: 30837697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular Ehlers-Danlos Syndrome: A Comprehensive Natural History Study in a Dutch National Cohort of 142 Patients.
    Demirdas S; van den Bersselaar LM; Lechner R; Bos J; Alsters SIM; Baars MJH; Baas AF; Baysal Ö; van der Crabben SN; Dulfer E; Giesbertz NAA; Helderman-van den Enden ATJM; Hilhorst-Hofstee Y; Kempers MJE; Komdeur FL; Loeys B; Majoor-Krakauer D; Ockeloen CW; Overwater E; van Tintelen PJ; Voorendt M; de Waard V; Maugeri A; Brüggenwirth HT; van de Laar IMBH; Houweling AC
    Circ Genom Precis Med; 2024 Jun; 17(3):e003978. PubMed ID: 38623759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular diagnosis in vascular Ehlers-Danlos syndrome predicts pattern of arterial involvement and outcomes.
    Shalhub S; Black JH; Cecchi AC; Xu Z; Griswold BF; Safi HJ; Milewicz DM; McDonnell NB
    J Vasc Surg; 2014 Jul; 60(1):160-9. PubMed ID: 24650746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Frameshift COL3A1 Variant in Vascular Ehlers-Danlos Syndrome.
    Olson SL; Murray ML; Skeik N
    Ann Vasc Surg; 2019 Nov; 61():472.e9-472.e13. PubMed ID: 31394236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular Ehlers-Danlos Syndrome With a Novel Missense COL3A1 Mutation Present With Pulmonary Complications and Iliac Arterial Dissection.
    Gu G; Yang H; Cui L; Fu Y; Li F; Zhou Z; Zheng Y
    Vasc Endovascular Surg; 2018 Feb; 52(2):138-142. PubMed ID: 29216800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next-generation sequencing and a novel COL3A1 mutation associated with vascular Ehlers-Danlos syndrome with severe intestinal involvement: a case report.
    Cortini F; Marinelli B; Seia M; De Giorgio B; Pesatori AC; Montano N; Bassotti A
    J Med Case Rep; 2016 Oct; 10(1):303. PubMed ID: 27799058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Splenic artery pathology presentation, operative interventions, and outcomes in 88 patients with vascular Ehlers-Danlos syndrome.
    Shalhub S; Nkansah R; El-Ghazali A; Hillenbrand CJ; Vaidya SS; Schwarze U; Byers PH
    J Vasc Surg; 2023 Aug; 78(2):394-404. PubMed ID: 37068529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type III collagen affects dermal and vascular collagen fibrillogenesis and tissue integrity in a mutant Col3a1 transgenic mouse model.
    D'hondt S; Guillemyn B; Syx D; Symoens S; De Rycke R; Vanhoutte L; Toussaint W; Lambrecht BN; De Paepe A; Keene DR; Ishikawa Y; Bächinger HP; Janssens S; Bertrand MJM; Malfait F
    Matrix Biol; 2018 Sep; 70():72-83. PubMed ID: 29551664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance and monitoring in vascular Ehlers-Danlos syndrome in European Reference Network For Rare Vascular Diseases (VASCERN).
    van de Laar IMBH; Baas AF; De Backer J; Blankenstein JD; Dulfer E; Helderman-van den Enden ATJM; Houweling AC; Kempers MJ; Loeys B; Malfait F; Robert L; Tanteles G; Frank M
    Eur J Med Genet; 2022 Sep; 65(9):104557. PubMed ID: 35779834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular Ehlers-Danlos syndrome, an often unrecognized clinical entity: a case report of a novel mutation in the COL3A1 gene.
    Huljev Frković S; Slišković AM; Toivonen M; Crkvenac Gregore A; Šutalo A; Vrkić Kirhmajer M
    Croat Med J; 2022 Aug; 63(4):394-398. PubMed ID: 36046937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of two iPSC lines from vascular Ehlers-Danlos Syndrome (vEDS) patients carrying a missense mutation in COL3A1 gene.
    Manhas A; Tripathi D; Noishiki C; Wu D; Liu L; Sallam K; Lee JT; Fukaya E; Sayed N
    Stem Cell Res; 2024 Sep; 79():103485. PubMed ID: 38944978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A New COL3A1 Mutation in Ehlers-Danlos Syndrome Vascular Type With Different Phenotypes in the Same Family.
    Cortini F; Marinelli B; Romi S; Seresini A; Pesatori AC; Seia M; Montano N; Bassotti A
    Vasc Endovascular Surg; 2017 Apr; 51(3):141-145. PubMed ID: 28183226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic aspects of the vascular type of Ehlers-Danlos syndrome (vEDS, EDSIV) in Japan.
    Watanabe A; Kosho T; Wada T; Sakai N; Fujimoto M; Fukushima Y; Shimada T
    Circ J; 2007 Feb; 71(2):261-5. PubMed ID: 17251678
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.